Dominique Baeten

21.8k total citations · 2 hit papers
321 papers, 16.1k citations indexed

About

Dominique Baeten is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Dominique Baeten has authored 321 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Rheumatology, 163 papers in Immunology and 79 papers in Hematology. Recurrent topics in Dominique Baeten's work include Spondyloarthritis Studies and Treatments (166 papers), Rheumatoid Arthritis Research and Therapies (145 papers) and Psoriasis: Treatment and Pathogenesis (86 papers). Dominique Baeten is often cited by papers focused on Spondyloarthritis Studies and Treatments (166 papers), Rheumatoid Arthritis Research and Therapies (145 papers) and Psoriasis: Treatment and Pathogenesis (86 papers). Dominique Baeten collaborates with scholars based in Netherlands, Belgium and United States. Dominique Baeten's co-authors include Maxime Dougados, Filip De Keyser, Paul P. Tak, Eric Veys, Elli Kruithof, Nataliya Yeremenko, Filip Van den Bosch, Leen De Rycke, Herman Mielants and Tineke Cantaert and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Dominique Baeten

314 papers receiving 15.8k citations

Hit Papers

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing ... 2011 2026 2016 2021 2015 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
    2015 732 citations Dominique Baeten, Joachim Sieper et al. profile →
  2. Spondyloarthritis
    2011 574 citations Maxime Dougados, Dominique Baeten The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Baeten Netherlands 71 9.8k 8.2k 3.8k 2.5k 1.4k 321 16.1k
Dimitrios T. Boumpas Greece 69 7.3k 0.7× 7.4k 0.9× 1.4k 0.4× 2.6k 1.0× 1.6k 1.2× 317 15.5k
Nobuyuki Miyasaka Japan 62 5.6k 0.6× 4.4k 0.5× 2.2k 0.6× 2.7k 1.1× 2.3k 1.7× 337 13.1k
Douglas J. Veale Ireland 64 6.4k 0.7× 4.3k 0.5× 2.2k 0.6× 3.0k 1.2× 1.5k 1.1× 289 13.1k
Joachim R. Kalden Germany 45 8.4k 0.9× 4.4k 0.5× 3.5k 0.9× 1.5k 0.6× 1.2k 0.9× 163 13.4k
Joachim R. Kalden Germany 44 5.9k 0.6× 5.6k 0.7× 2.1k 0.5× 2.0k 0.8× 1.2k 0.9× 103 11.7k
Christopher T. Ritchlin United States 61 10.1k 1.0× 9.6k 1.2× 5.4k 1.4× 2.0k 0.8× 1.7k 1.3× 347 15.3k
Barry Bresnihan Ireland 65 7.3k 0.7× 4.0k 0.5× 2.3k 0.6× 2.6k 1.0× 1.5k 1.1× 233 12.9k
Costantino Pitzalis United Kingdom 65 4.8k 0.5× 6.2k 0.8× 1.3k 0.3× 3.3k 1.3× 2.2k 1.6× 334 14.2k
Jill P. Buyon United States 74 9.8k 1.0× 7.1k 0.9× 1.5k 0.4× 2.0k 0.8× 599 0.4× 320 17.1k
Tore Saxne Sweden 59 8.0k 0.8× 2.8k 0.3× 1.7k 0.4× 1.6k 0.6× 1.1k 0.8× 202 12.1k

Countries citing papers authored by Dominique Baeten

Since Specialization
Citations

This map shows the geographic impact of Dominique Baeten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Baeten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Baeten more than expected).

Fields of papers citing papers by Dominique Baeten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Baeten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Baeten. The network helps show where Dominique Baeten may publish in the future.

Co-authorship network of co-authors of Dominique Baeten

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Baeten. A scholar is included among the top collaborators of Dominique Baeten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Baeten. Dominique Baeten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tok, Melissa N. van, Iris C. Blijdorp, Carmen A. Ambarus, et al.. (2020). Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis. The Journal of Experimental Medicine. 217(10). 31 indexed citations
2.
Kristyanto, Hendy, Linda M. Slot, Ellen I. H. van der Voort, et al.. (2020). Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis. Science Translational Medicine. 12(570). 73 indexed citations
3.
Heijde, Désirée van der, Lianne S. Gensler, Atul Deodhar, et al.. (2020). Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Annals of the Rheumatic Diseases. 79(5). 595–604. 97 indexed citations
4.
Hoepel, Willianne, Steven W. de Taeye, Alwin J. van der Ham, et al.. (2020). IgG Subclasses Shape Cytokine Responses by Human Myeloid Immune Cells through Differential Metabolic Reprogramming. The Journal of Immunology. 205(12). 3400–3407. 16 indexed citations
5.
6.
Landewé, Robert, T. Nurminen, O. Davies, & Dominique Baeten. (2018). A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis ‘CRP-negative’. Arthritis Research & Therapy. 20(1). 209–209. 21 indexed citations
7.
Hansen, Ivo S., et al.. (2017). Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI–TLR Cross-Talk. The Journal of Immunology. 199(12). 4124–4131. 44 indexed citations
8.
Hooge, Manouk de, Michiel A. J. van de Sande, Lonneke van Hoeven, et al.. (2017). A Positive MRI of the Sacroiliac Joints Is Not Specific for Axial Spondyloarthritis but Frequently Occurs in Healthy Individuals. Arthritis & Rheumatism. 69. 4 indexed citations
9.
Moens, Sophie J. Bernelot, Sander I. van Leuven, Kang H. Zheng, et al.. (2016). Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques. PLoS ONE. 11(11). e0164690–e0164690. 10 indexed citations
10.
Angiolilli, Chiara, Pawel A. Kabala, Aleksander M. Grabiec, et al.. (2016). Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Annals of the Rheumatic Diseases. 76(1). 277–285. 115 indexed citations
11.
Rycke, Leen De, Barbara H. Barendregt, Jacqueline E Paramarta, et al.. (2012). Anti-TNF treatment blocks the induction of T cell-dependent humoral responses. Annals of the Rheumatic Diseases. 72(6). 1037–1043. 77 indexed citations
12.
Emery, P., Dominique Baeten, Joachim Sieper, et al.. (2012). EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS. Lara D. Veeken. 51. 21–21. 6 indexed citations
13.
Baraliakos, Xenofon, Jerry Braun, Didier Laurent, et al.. (2012). Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis.. Data Archiving and Networked Services (DANS). 64(10). 4 indexed citations
14.
Dougados, Maxime & Dominique Baeten. (2011). Arthritis 2 Spondyloarthritis. The Lancet. 377(9783). 2127–2137. 307 indexed citations
15.
Vandooren, Bernard, Troy Noordenbos, Carmen A. Ambarus, et al.. (2009). Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis & Rheumatism. 60(4). 966–975. 130 indexed citations
16.
Rycke, Leen De, Dominique Baeten, Elli Kruithof, et al.. (2005). IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications. Ghent University Academic Bibliography (Ghent University). 3 indexed citations
17.
Rycke, Leen De, Bernard Vandooren, Elli Kruithof, et al.. (2005). Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade. Ghent University Academic Bibliography (Ghent University). 4 indexed citations
18.
Kruithof, Elli, Leen De Rycke, Filip De Keyser, et al.. (2005). Identification of synovial biomarkers of response to treatment in spondyloarthropathy. Ghent University Academic Bibliography (Ghent University). 52(9). 633. 1 indexed citations
19.
Rycke, Leen De, Tineke Cantaert, Elli Kruithof, et al.. (2005). Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase are pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
20.
Baeten, Dominique, Eric Veys, & Filip De Keyser. (2002). Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al - Reply.. Ghent University Academic Bibliography (Ghent University). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios T. Boumpas Breakdown of academic impact, for papers by Nobuyuki Miyasaka Breakdown of academic impact, for papers by Douglas J. Veale Breakdown of academic impact, for papers by Joachim R. Kalden Breakdown of academic impact, for papers by Joachim R. Kalden Breakdown of academic impact, for papers by Christopher T. Ritchlin Breakdown of academic impact, for papers by Barry Bresnihan Breakdown of academic impact, for papers by Costantino Pitzalis Breakdown of academic impact, for papers by Jill P. Buyon Breakdown of academic impact, for papers by Tore Saxne
Rankless by CCL
2026